Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-CO1 pseudogene 17 (MTCO1P17) is a pseudogene in the human genome corresponding to the mitochondrial cytochrome c oxidase subunit I gene (MT-CO1)[3][4]. Pseudogenes are gene sequences that resemble functional genes but typically lack the ability to encode functional proteins. This particular pseudogene is annotated in human genomic databases as nonfunctional and is distinct from the active MT-CO1 gene, which encodes the catalytic subunit I of mitochondrial cytochrome c oxidase, a key enzyme in cellular respiration. MTCO1P17 has no known biological function, is not involved in disease mechanisms, is not a therapeutic target, and has no associated drugs or biomarker roles[3][4]. If you are seeking information on the protein-coding MT-CO1 gene or its disease associations, refer to "mitochondrially encoded cytochrome c oxidase I" (MT-CO1 or COX1)[1][2]. Key point: MTCO1P17 is a nonfunctional pseudogene, not an enzyme, receptor, or therapeutic target[3][4]. There appears to be some confusion or incorrectness if MTCO1P17 is being referenced as a target molecule; the active enzyme is MT-CO1 (COX1)[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CO1 pseudogene 17 (MTCO1P17).